Peter W. Getsinger - 14 Dec 2024 Form 4 Insider Report for ARGAN INC (AGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Dec 2024, 16:15:08 UTC
Prior SEC filing
01 Nov 2024
Next SEC filing
27 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Peter W. Getsinger

Key filing fact

Peter W. Getsinger filed Form 4 for ARGAN INC (AGX) on 16 Dec 2024.

Key facts

  • This page summarizes Peter W. Getsinger's Form 4 filing for ARGAN INC (AGX).
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 16 Dec 2024, 16:15.

Change

  • Previous filing in this sequence was filed on 01 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,757
Change %
+15%
Price
$0.000000
Shares after
13,757
Date
14 Dec 2024
Ownership
Direct
Footnotes
F1
AGX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+835
Change %
+6.1%
Price
$0.000000
Shares after
14,592
Date
14 Dec 2024
Ownership
Direct
Footnotes
F2
AGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
267
Date
14 Dec 2024
Ownership
Held in Children's Trust
AGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
133
Date
14 Dec 2024
Ownership
Held in Custody Account for Child

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGX transaction Derivative

Time-Based Restricted Stock Units

Award

Transaction value
$0
Shares
+388
Change %
+6.5%
Price
$0.000000
Shares after
6,388
Date
12 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
388
Exercise price
$0.000000
Footnotes
F3
AGX transaction Derivative

Time-Based Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,750
Change %
-27%
Price
$0.000000
Shares after
4,638
Date
14 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,750
Exercise price
$0.000000
Footnotes
F1
AGX transaction Derivative

Time-Based Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-833
Change %
-18%
Price
$0.000000
Shares after
3,805
Date
14 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
833
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends.

Footnote F2

Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends.

Footnote F3

On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .